CAM
TMO icon

Claret Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Claret Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Sell
626
-114
-15% -$54.7K 0.03% 139
2026
Q1 		$364K Buy
740
+132
+22% +$71.6K 0.04% 152
2025
Q4 		$352K Buy
608
+29
+5% +$16.4K 0.04% 146
2025
Q3 		$281K Buy
579
+7
+1% +$3.26K 0.03% 181
2025
Q2 		$232K Buy
+572
New +$239K 0.03% 364
2024
Q4 		– Sell
-360
Closed -$223K – 351
2024
Q3 		$223K Buy
+360
New +$213K 0.04% 245

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Claret Asset Management's TMO Position: Q2 2026 in Review

Claret Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $54.7K and leaving 626 shares worth $314K. The position accounts for 0.03% of the portfolio, ranked #139.

Claret Asset Management first reported a position in TMO in Q3 2024 and has held it in 6 quarters since. The position peaked at $364K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Claret Asset Management held 626 shares of Thermo Fisher Scientific worth $314K as of Q2 2026.
  • Claret Asset Management sold 114 Thermo Fisher Scientific shares in Q2 2026, an estimated $54.7K.
  • Thermo Fisher Scientific made up 0.03% of Claret Asset Management's portfolio in Q2 2026, its #139 holding.
  • Claret Asset Management first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 6 quarters since.
  • Claret Asset Management's Thermo Fisher Scientific position peaked at $364K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.